CONNECT WITH US
HealthTech

HealthTech

One year after taking ibogaine, veterans find continued relief from PTSD

Medical Xpress logo

Published on

Add as a preferred source on Google
One year after taking ibogaine, veterans find continued relief from PTSD

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A few years ago, 30 special forces veterans suffering for years with the psychiatric consequences of multiple traumatic brain injuries—including post-traumatic stress disorder, depression and anxiety—traveled to Mexico to undergo a little-known psychedelic therapy called ibogaine.

Derived from the root of a West African shrub and long used in traditional spiritual ceremonies, ibogaine had been gaining a reputation for helping traumatized veterans at the end of their rope. A group of them had agreed to be studied by Stanford Medicine researchers before and after the therapy.

Patrick Flatley, a former Green Beret who served multiple tours in Iraq and Afghanistan, was among them. He had joined the U.S. Army at age 19 and racked up head injuries early and often—first as a paratrooper jumping out of airplanes with 70 pounds (32 kilograms) strapped to his back, then as a mortarman handling explosive weapons.

In 1994, he was a Green Beret sniper when two U.S. Army helicopters were mistakenly shot down by U.S. Air Force fighter jets in northern Iraq. Flatley had frequently ridden on those helicopters, but that day a last-minute personnel change bumped him from his spot.

He was plagued by nightmares in the aftermath of the accident. "It was the same over and over. I never had a good dream for 25 years," he said. Over more tours, he accumulated more head traumas and physical injuries, including a broken back.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.